ADAMO, Vincenzo

ADAMO, Vincenzo  

Dipartimento di Patologia Umana dell'adulto e dell'età evolutiva "Gaetano Barresi"  

Mostra records
Risultati 1 - 20 di 263 (tempo di esecuzione: 0.033 secondi).
Titolo Data di pubblicazione Autore(i) File
A double-blind randomized study comparing intramuscular (i.m.) granisetron with i.m. granisetron plus dexamethasone in the prevention of delayed emesis induced by cisplatin 1-gen-1999 Conte, P; Ricci, S; Antonuzzo, A; Allegrini, G; Palazzo, S; Liguori, V; Mastroianni, C; Manzione, L; Bilancia, D; Dinota, A; DI COSTANZO, F; Gasperoni, S; Sdrobolini, A; Montinari, F; Mastore, M; Casartelli, C; Danese, S; Richiardi, G; Sismondi, P; Locatelli, Mc; D'Antona, A; Luporini, G; Ambrosini, G; Giustini, L; Bascioni, R; Acito, L; Recchia, F; DE FILIPPIS, S; Rosselli, M; Vinante, O; Rossetti, F; Azzarello, G; Lucenti, A; Galligioni, E; Brugnara, S; Rossi, A; AL VESUVIO, Ss; Bumma, C; Donadio, M; Cattaneo, Mt; Aapro, Ms; Libretti, A; Nole, F; Bizzarri, M; Facco, R; Buzzi, F; Brugia, M; Colucci, G; Giotta, F; Manente, P; Vicario, G; Martoni, A; Angelelli, B; Pusceddu, G; Salaris, G; Comella, G; Gravina, A; Morrica, B; Rampello, G; Colosini, G; Migliosi, G; Temperilli, L; Monno, D; Amadori, D; Maltoni, M; Ammuni, G; Villanucci, A; Cocconi, G; Bella, M; Farris, A; Sanna, G; Gebbia, V; Testa, A; Iacono, G; Lopresti, G; Pergola, M; Gridelli, C; Adamo, Vincenzo; Altavilla, Giuseppe; Barbieri, P; Pisoni, G.
A new method for titration of oral transmucosal fentanyl citrate (OTFC) starting dose in cancer patients. 1-gen-2006 Scandurra, G; Ferraro, Giuseppa; Franchina, Tindara; Chiofalo, G; Zanghi', Mariangela; Festa, V; Pastura, G; Adamo, Vincenzo
A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck. 1-gen-2008 Caponigro, F; Romano, C; Milano, A; Solla, R; Franchin, G; Adamo, Vincenzo; Mari, E; Morrica, B; Pepe, S.
A PHASE II STUDY (21 DAY REGIMEN) OF GEMCITABINE AND CISPLATIN IN TRANSITIONAL CELL CARCINOMA OF BLADDER 1-gen-2001 Adamo, Vincenzo; Scimone, A.; DE VINCENZO, F.; D'Angelo, A.; Ferraro, Giuseppa; Altavilla, Giuseppe; Garipoli, Claudia; Zanghi', Mariangela
A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. 1-gen-2005 DE PLACIDO, S; DE LAURENTIIS, M; DE LENA, M; Lorusso, V; Paradiso, A; D'Aprile, M; Pistillucci, G; Farris, A; Sarobba, Mg; Palazzo, S; Manzione, L; Adamo, Vincenzo; Palmeri, S; Ferrau, F; Lauria, R; Pagliarulo, C; Petrella, G; Limite, G; Costanzo, R; Bianco, Ar; GOCSI COOPERATIVE, Group
A study of endometrial adenocarcinoma treated with tamoxifen by scanning and transmission electron microscopy. 1-gen-1985 Rigano, A; Irato, S; Scalisi, R; Adamo, Vincenzo; Altavilla, Giuseppe; Buda, C.
Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis. 1-gen-2010 Franchina, Tindara; Adamo, Barbara; Caristi, Nicola; G., Chiofalo; G., Toscano; Colonese, Francesca; Denaro, Nerina; Ricciardi, GIUSEPPINA ROSARIA; A., Russo; Adamo, Vincenzo; University, Polyclinic; Messina, Italy; School of, Medicine; University, Polyclinic; Palermo, Italy
Activity and tolerability of cisplatin (CDDP) and fotemustine (FTM) in non-small cell lung cancer (NSCLC) patients (PTS) with brain metastases (BM): A multicentric phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM). 1-gen-2009 D., Galetta; V., Gebbia; F., Ferraù; F., Carrozza; S., Cigolari; P., Russo; F., Calista; Adamo, Vincenzo; G., Colucci
ACTIVITY AND TOXICITY OF GEMCITABINE AND GEMCITABINE + VINORELBINE IN ADVANCED NSCLC EDERLY PATIENTS .PHASE II DATA FROM THE MULTICENTER ITALIAN LUNG CANCER IN THE ELDERLY STUDY(MILES) RANDOMIZED TRIAL 1-gen-2001 C., Gridelli; S., Cigolari; C., Gallo; L., Manzione; G. P., Ianniello; L., Frontini; F., Ferrau'; Robiati, S. F.; Adamo, Vincenzo; G., Gasparini; S., Novello; F., Perrone
Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports. 1-gen-2012 Franchina, Tindara; Adamo, Barbara; Ricciardi, GIUSEPPINA ROSARIA; Caristi, Nicola; Agostino, RITA MARIA; Proto, Claudia; Adamo, Vincenzo
Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial. 1-gen-2012 Cognetti, F; Ruggeri, Em; Felici, A; Gallucci, M; Muto, G; Pollera, Cf; Massidda, B; Rubagotti, A; Giannarelli, D; Boccardo, F; Cantiani, R; Adamo, Vincenzo; Aglietta, M; Bertetto, O; Cetto, Gl; Orlandini, P; Ferrazzi, E; Nardi, M; Manzione, L; Porcile, G; Lentini, M; Breda, E; Gamucci, T; Tummarello, D; Dogliotti, L; Tumolo, S; Motta, M; Lo Russo, V; De Grande, G; Sacco, C; Gaion, F; Lavarello, A; Nuzzo, A; Clerico, M; Aragona, C; Gernone, A; Morelli, F; Cupini, ; Mattioli, R; Marra, A; Antimi, M; Silingardi, V; Labianca, R; Martoni, A; Bortolussi, V; Luoni, M; Rosabian, A; Di Vito, F; Catalano, G; Gebbia, N.
AIOM Conference 2004. Docetaxel: a recent conquest in the adjuvant therapy of breast cancer 1-gen-2004 Adamo, Vincenzo
An immunohistochemical investigation of pre-metastatic niche (PMN) in node-negative invasive breast carcinomas 1-gen-2010 Ieni, Antonio; Simone, Angela; Giuffre', Giuseppe; Grosso, Maddalena; Scarfi', Rosa; F. M., Plutino; Colonese, Francesca; Adamo, Vincenzo; Tuccari, Giovanni
Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients 1-gen-2015 Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ieni, Antonio; Licata, Luana; Cardia, Roberta; Ferraro, Giuseppa; Franchina, Tindara; Tuccari, Giovanni; Adamo, Vincenzo
Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC). 1-gen-2013 Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ferraro, Giuseppa; Franchina, Tindara; Zanghi', Mariangela; Buda, Carmelo; Trimarchi, Giuseppe; Cardia, R; Tuccari, Giovanni; Adamo, Vincenzo
Antiblastic treatment of advanced cervical carcinoma and its recurrences: assessment of four different polychemotherapies used for a decade. 1-gen-1989 Rigano, A; Adamo, Vincenzo; Altavilla, Giuseppe; D'Aquino, S.
Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy 1-gen-2017 Lucchesi, Simona; Marciano', Ilaria; Paolo, Panagia; Intelisano, Rosanna; Maria Pia Randazzo, ; Sgroi, Carmela; Altavilla, Giuseppe; Santarpia, Mariacarmela; Adamo, Vincenzo; Franchina, Tindara; Francesco, Ferraù; Paolina, Reitano; Trifiro', Gianluca
Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel 1-gen-2018 Russo, A.; Franchina, T.; Ricciardi, G. R. R.; Battaglia, A.; Scimone, A.; Berenato, R.; Giordano, A.; Adamo, V.
Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study. 1-gen-2012 Clavarezza M; Mustacchi G; Casadei Giardini A; Del Mastro L; de Matteis A; Riccardi F; Adamo V; Aitini E; Amoroso D; Marchetti P; Carrozza F; Maiello E; Giotta F; Dondi D; Venturini M; Gori S.
Biological parameters in breast cancer. 1-gen-1996 Costa G;Lascari G;Aragona M;Ferlazzo G;Adamo V;Gangemi R;Geraci O;Pastura G;Mesiti M;Castagnetta L